Clofibrate-induced ventricular arrhythmia.
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002395:Catecholamines / Q000652:urine; D002524:Cerebellar Ataxia / Q000139:chemically induced; D003402:Creatine Kinase / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008875:Middle Aged; D009206:Myocardium / Q000201:enzymology; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010672:Phenytoin / Q000627:therapeutic use; D005082:Physical Exertion; D011188:Potassium / Q000097:blood; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects; D014973:Xanthomatosis / Q000188:drug therapy*
D000924:Anticholesteremic Agents; D002395:Catecholamines; D010672:Phenytoin; D011433:Propranolol; D003402:Creatine Kinase; D011342:Procainamide; D011188:Potassium